These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35149232)

  • 1. COVID-19 vaccines: Considering sex differences in efficacy and safety.
    Jensen A; Stromme M; Moyassari S; Chadha AS; Tartaglia MC; Szoeke C; Ferretti MT
    Contemp Clin Trials; 2022 Apr; 115():106700. PubMed ID: 35149232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exclusion of Reproductive-aged Women in COVID-19 Vaccination and Clinical Trials.
    Kons KM; Wood ML; Peck LC; Hershberger SM; Kunselman AR; Stetter C; Legro RS; Deimling TA
    Womens Health Issues; 2022; 32(6):557-563. PubMed ID: 36075817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [SARS-CoV-2 vaccines].
    Benfield TL; Helweg-Larsen J
    Ugeskr Laeger; 2021 Mar; 183(10):. PubMed ID: 33734065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equity in coronavirus disease 2019 vaccine development and deployment.
    Modi N; Ayres-de-Campos D; Bancalari E; Benders M; Briana D; Di Renzo GC; Fonseca EB; Hod M; Poon L; Cortes MS; Simeoni U; Tscherning C; Vento M; Visser GHA; Voto L
    Am J Obstet Gynecol; 2021 May; 224(5):423-427. PubMed ID: 33460584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials.
    Lim HX; Arip M; Yahaya AAA; Jazayeri SD; Poppema S; Poh CL
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1286-1304. PubMed ID: 34856768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine safety - is the SARS-CoV-2 vaccine any different?
    Tau N; Yahav D; Shepshelovich D
    Hum Vaccin Immunother; 2021 May; 17(5):1322-1325. PubMed ID: 33270474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion of Pregnant and Lactating Persons in COVID-19 Vaccination Efforts.
    Riley LE; Jamieson DJ
    Ann Intern Med; 2021 May; 174(5):701-702. PubMed ID: 33493013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing initial COVID-19 vaccine attitudes among pregnancy-capable healthcare workers.
    Perez MJ; Paul R; Raghuraman N; Carter EB; Odibo AO; Kelly JC; Foeller ME
    Am J Obstet Gynecol MFM; 2022 Mar; 4(2):100557. PubMed ID: 34952227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of approved COVID-19 vaccines.
    Jamkhande A; Khairnar MR; Gavali N; Patil Y; Kapare SS; Bhosale KP
    Rocz Panstw Zakl Hig; 2021; 72(3):245-252. PubMed ID: 34553878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of pandemic prevalence on the reported efficacy of SARS-CoV-2 vaccines.
    Sharma R; Anand A
    PLoS One; 2022; 17(4):e0266271. PubMed ID: 35381023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expecto Patronum! Leveraging the Positive Force of COVID-19 Vaccines for Pregnant and Lactating Individuals.
    Malinowski AK; Whittle W; Murphy K; Kingdom J
    J Obstet Gynaecol Can; 2021 Oct; 43(10):1184-1187. PubMed ID: 34000442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological consideration of COVID-19 infection and vaccines in pregnancy.
    Mohapatra S; Ananda P; Tripathy S
    J Chin Med Assoc; 2022 May; 85(5):537-542. PubMed ID: 35316227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the safety and efficacy of current COVID-19 vaccines.
    Huang Z; Su Y; Zhang T; Xia N
    Front Med; 2022 Feb; 16(1):39-55. PubMed ID: 35122210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccines: concerns beyond protective efficacy and safety.
    Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
    Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 vaccines: what do we know so far?
    Dhillon P; Altmann D; Male V
    FEBS J; 2021 Sep; 288(17):4996-5009. PubMed ID: 34288409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misrepresentation about vaccines that are scaring women.
    Moodley J; Khaliq OP; Mkhize PZ
    Afr J Prim Health Care Fam Med; 2021 Jun; 13(1):e1-e2. PubMed ID: 34212737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.